Edesa Biotech Announces Pricing of $25.0 Million Public Offering
· financialpost.com
TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on de…
Article content
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Sect...